clinicopathologic models in prostate cancer: impact of a 22-gene genomic classifier
Published 4 years ago • 63 plays • Length 1:34Download video MP4
Download video MP3
Similar videos
-
1:46
genomic and clinical features of spop mutations in prostate cancer
-
2:58
genomic classifiers for prostate cancer risk statification
-
3:12
impact of hsd3b1 gene alterations on treatment response in patients with prostate cancer
-
2:51
prognostic value of the spop mutant genomic subclass in prostate cancer
-
1:23
genomic testing impacts treatment decisions in prostate cancer
-
19:15
prostate cancer genetics and genomics
-
4:46
decipher prostate genomic classifier by veracyte - a different approach to prostate cancer
-
11:03
biomarkers for prostate cancer: whom to treat
-
18:38
genetics & genomics of prostate cancer – 2023 zero prostate cancer summit
-
15:41
dr. concepcion - genetic testing and prostate cancer 1
-
30:17
prostate cancer, treatment, and clinical trials: expert q&a
-
4:58
genomic prostate score for localized prostate cancer
-
10:13
the role of genetic testing in prostate cancer
-
2:57
role of genomic profiling in the management of intermediate-risk prostate cancer
-
4:34
the role of genomics in newly diagnosed prostate cancer: ashley ross, md, phd
-
50:38
the impact of a genomic assay on urologist treatment preference in active surveillance-eligible men
-
37:57
the future of prostate cancer research and treatment
-
58:07
genetic testing in prostate cancer: considerations for urologists and their patients
-
4:25
the impact of dna repair defects on prostate cancer